Publication:

Multianalyte nano-biosensor diagnostics: advances through microfluidic and AI integration

Date

 
cris.virtual.department#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.department#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.department#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.orcid0000-0002-1603-4518
cris.virtual.orcid0000-0002-9880-7413
cris.virtual.orcid0000-0002-0925-2517
cris.virtualsource.departmentdb76126e-7048-46aa-949c-5467e57c3965
cris.virtualsource.departmentee50dc6d-752b-4390-9626-e1c325acf206
cris.virtualsource.department80e85828-317e-4a13-87b1-abd4cb8dea7e
cris.virtualsource.orciddb76126e-7048-46aa-949c-5467e57c3965
cris.virtualsource.orcidee50dc6d-752b-4390-9626-e1c325acf206
cris.virtualsource.orcid80e85828-317e-4a13-87b1-abd4cb8dea7e
dc.contributor.authorPathak, Shashikant
dc.contributor.authorBazazordeh, Shadi
dc.contributor.authorCamlica, Buse
dc.contributor.authorDelcorte, Arnaud
dc.contributor.authorTzouvadaki, Ioulia
dc.date.accessioned2026-11-19T16:02:27Z
dc.date.available2026-11-19T16:02:27Z
dc.date.createdwos2026-02-05
dc.date.issued2026
dc.description.abstractRecent advances in nano-biosensors are reshaping clinical diagnostics by enabling multiplexed biomarker detection with high sensitivity and precision. This mini-review examines both the opportunities and challenges in translating nano-biosensor technologies toward clinically relevant point-of-care (PoC) and wearable devices. We emphasize the integration of multiplexing strategies with microfluidic platforms and adaptive artificial intelligence (AI) algorithms, which together enable real-time, high-throughput, and personalized health monitoring. Electrochemical and optical transduction approaches for multi-biomarker diagnostics are discussed, along with the role of microfluidic integration in enhancing sensor performance through precise sample processing, reduced reagent use, and simultaneous biomarker detection. A comparative overview of multiplexing approaches, including spatial, spectral, and temporal encoding is presented, with particular attention to sensor surface regeneration for device reusability. Furthermore, we explore the role of adaptive AI algorithms in individualising diagnostics to diverse patient groups while addressing key ethical and regulatory considerations such as algorithm transparency, patient data protection, and compliance with evolving medical device standards. By drawing together insights across nano-biosensor design, microfluidics, and AI, this mini review provides practical guidance for advancing next-generation diagnostic platforms toward clinical translation.
dc.description.wosFundingTextThe author(s) declared that financial support was received for this work and/or its publication. This work was supported by the Bijzonder Onderzoeksfonds under the Grant No. BOF.STG.2023.0008.01 and EOS ALMODCONS (Artificial Lithographic Model for Corneal Drug Screening) research project under the Grant No. FWO G0J3322N.
dc.identifier.doi10.3389/fbioe.2025.1715719
dc.identifier.issn2296-4185
dc.identifier.pmidMEDLINE:41625077
dc.identifier.urihttps://imec-publications.be/handle/20.500.12860/60886
dc.language.isoeng
dc.provenance.editstepusergreet.vanhoof@imec.be
dc.publisherFRONTIERS MEDIA SA
dc.source.beginpage1715719
dc.source.journalFRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
dc.source.numberofpages12
dc.source.volume13
dc.subject.keywordsELECTROCHEMICAL BIOSENSORS
dc.subject.keywordsNANOMATERIALS
dc.subject.keywordsPROTEINS
dc.subject.keywordsDNA
dc.title

Multianalyte nano-biosensor diagnostics: advances through microfluidic and AI integration

dc.typeJournal article review
dspace.entity.typePublication
imec.internal.crawledAt2026-04-07
imec.internal.sourcecrawler
imec.internal.wosCreatedAt2026-04-07
Files

Original bundle

Name:
fbioe-13-1715719.pdf
Size:
6.44 MB
Format:
Adobe Portable Document Format
Description:
Published
Publication available in collections: